Answers are grounded in this paper and cite their sources.
Unrestrained oncogene activity triggers DNA damage. Cancer cells exploit various stratagems to deal with this potentially lethal event. We found that hematologic cancer cells inactivate the Hippo co-activator Yes-associated protein 1 (YAP1). A synthetic lethal approach is proposed whereby inhibition of the serine/threonine kinase 4 (STK4) could be exploited to restore YAP1 levels in hematologic cancers.
No takes yet. Share an insight, caveat, or question.
Cottini et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: